Last updated: November 29, 2021
Sponsor: Göteborg University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Endometriosis
Chronic Pain
Pain
Treatment
N/AClinical Study ID
NCT05152264
274998
Ages 18-100 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age ≥18 years
- Consents to participation in the study
- Verified endometriosis (by laparoscopy or ultrasound).
- Chronic endometriosis-related pain (> 3 months), available for TENS treatment
- Functioning, stable endometriosis-specific hormonal drug therapy. Theendometriosis-specific drug therapy must be unchanged for the last 3 months and nogynecological surgical procedures for the treatment of endometriosis are plannedduring the next 7 months (during study participation). The endometriosis-specific drugtherapy does not refer to analgesic therapy for symptom relief ofendometriosis-related pain.
Exclusion
Exclusion Criteria:
- Patient with inability to understand and use written and spoken Swedish
- Patient with pacemaker and/or ICD or other electronic implants
- Patient with impaired sensation over the painful area
- Malignant disease with an expected survival <12 months
- Alcohol or substance abuse
- Serious untreated psychiatric illness and/or psychological condition that is theprimary determinant of the patient's condition
- Participating in another intervention study with possible impact on current studyoutcome measures
- Patient who is using >90 morphine equivalents/day
- Patient who is electro-acupuncture
- Pregnancy
Study Design
Total Participants: 40
Study Start date:
November 12, 2021
Estimated Completion Date:
December 31, 2025
Study Description
Connect with a study center
Pain Centre, Department of Anaesthesiology and Intensive Care Medicine Östra, Sahlgrenska University Hospital, Region Västra Götaland
Gothenburg,
SwedenActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.